Inventor
KIM JEE H
US18 patents
⚠️ This page may combine multiple inventors who share the name “KIM JEE H”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
REGENERON PHARMA
13 patentsUS9644018B2May 9, 2017
Antibody modulators of APLNR
REGENERON PHARMA13 citations91
US9120851B2Sep 1, 2015
Human antibodies to human angiopoietin-like protein 4
REGENERON PHARMA11 citations83
US8354103B2Jan 15, 2013
Human antibodies to human angiopoietin-like protein 4
REGENERON PHARMA5 citations83
US11884736B2Jan 30, 2024
Antibodies which bind to glucagon-like peptide 1 receptor (GLP1R)
REGENERON PHARMA2 citations72
US10947310B2Mar 16, 2021
Fusion protein comprising apelin and an anti-APLNR antibody
REGENERON PHARMA1 citations72
US10626173B2Apr 21, 2020
Method for treating pathological angiogenesis by administering an antibody that inhibits APLNR
REGENERON PHARMA2 citations72
US10189901B2Jan 29, 2019
Methods for improving cardiac function by administering an antibody that activates APLNR
REGENERON PHARMA2 citations72
US10155811B2Dec 18, 2018
APLNR modulators and uses thereof
REGENERON PHARMA2 citations72
US12421317B2Sep 23, 2025
Polynucleotides encoding anti-glucagon-like peptide 1 receptor (GLP1R) antagonist antibodies
REGENERON PHARMA0 citations62
US11642390B2May 9, 2023
Method of treatment with a fusion protein comprising apelin and an anti-APLNR antibody
REGENERON PHARMA0 citations61
US12441797B2Oct 14, 2025
Anti-FC ϵ-R1 α (FCϵR1α) antibodies, bispecific antigen-binding molecules that bind FCϵR1α and CD3, and uses thereof
REGENERON PHARMA0 citations60
US11578127B2Feb 14, 2023
Anti-Fc epsilon-R1 alpha (FcεR1α) antibodies, bispecific antigen-binding molecules that bind FcεR1α and CD3, and uses thereof
REGENERON PHARMA1 citations60
US12559576B2Feb 24, 2026
CD20-PD1 binding molecules and methods of use thereof
REGENERON PHARMA0 citations59